Cargando…
Percutaneous Atrial Septal Defect Closure Using the Occlutech Figulla Device in Adults: More than 800 Patient-Years of Follow-Up
PURPOSE: The Occlutech Figulla occluder has been proven safe and effective at midterm follow-up after percutaneous atrial septal defect (ASD) closure. We describe the safety and efficacy at long-term follow-up in adults. METHODS: All consecutive adult patients that underwent ASD closure between 2008...
Autores principales: | Snijder, R. J. R., Renes, L. E., Bosshardt, D., Suttorp, M. J., ten Berg, J. M., Post, M. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042503/ https://www.ncbi.nlm.nih.gov/pubmed/32140088 http://dx.doi.org/10.1155/2020/7136802 |
Ejemplares similares
-
Transcatheter Atrial Septal Defect Closure Using Occlutech Figulla Device: A Two-Center Experience
por: Mortezaeian, Hojat, et al.
Publicado: (2013) -
Successful retrieval of a Figulla Occlutech septal occluder - embolized device stability and potential solutions
por: Sadiq, Masood, et al.
Publicado: (2016) -
Microtransesophageal Echocardiographic Guidance during Percutaneous Interatrial Septal Closure without General Anaesthesia
por: Snijder, Roel J. R., et al.
Publicado: (2020) -
Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla(®) Flex II Occluder
por: Neuser, Jonas, et al.
Publicado: (2016) -
Percutaneous closure of a patent foramen ovale after cryptogenic stroke
por: Snijder, R. J. R., et al.
Publicado: (2017)